ASCO Annual Meeting: New Therapeutic Approaches To Breast Cancer Highlighted
Oral Capecitabine Equal To 5FU-Leucovorin In Adjuvant Stage III Colon Cancer Treatment
Weekly Paclitaxel Better Than Every Three Weeks
Pharmacogenomics May Lead To Individualized Treatment
ASCO Recommends Against Chemo In Stage II Colon Cancer
NCI-Approved Clinical Trials
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis - Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- Lawsuits brought against Tempus AI raise more questions than answers about DNA privacy in the AI era
- GRAIL’s Megan Hall: “I think we can be confident that there is clinical benefit to implementing this technology. And I think that’s really hard to argue with.”
Mainstream epidemiologists beg to differ - NCI’s Philip Castle on NHS-Galleri results: “I’m sorry that it didn’t work, but it keeps the national conversation going.”
Castle is “disappointed” by Galleri results but not discouraged by implications for MCDs









